Loading...
19 results
Search Results
Now showing 1 - 10 of 19
- Tracking Arachis hypogaea Allergen in Pre-Packaged Foodstuff: A Nanodiamond-Based Electrochemical Biosensing ApproachPublication . Freitas, Maria; Carvalho, André; Nouws, Henri; Delerue-Matos, CristinaThe present work reports a nanodiamond-based voltammetric immunosensing platform for the analysis of a food allergen (Ara h 1) present in peanuts (Arachis hypogaea). The possibility of the usage of nanodiamonds (d = 11.2 ± 0.9 nm) on screen-printed carbon electrodes (SPCE/ND) in a single-use two-monoclonal antibody sandwich assay was studied. An enhanced electroactive area (~18%) was obtained and the biomolecule binding ability was improved when the 3D carbon-based nanomaterial was used. The antibody-antigen interaction was recognized through the combination of alkaline phosphatase with 3-indoxyl phosphate and silver ions. Linear Sweep Voltammetry (LSV) was applied for fast signal acquisition and scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS) support the voltammetric approach and confirm the presence of silver particles on the electrode surface. The proposed immunosensor provided a low limit of detection (0.78 ng·mL−1) and highly precise (RSD < 7.5%) and accurate results. Quantification of Ara h 1 in commercial foodstuffs (e.g., crackers, cookies, protein bars) that refer to the presence of peanuts (even traces) on the product label was successfully achieved. The obtained data were in accordance with recovery results (peanut addition, %) and the foodstuff label. Products with the preventive indication “may contain traces” revealed the presence of peanuts lower than 0.1% (m/m). The method’s results were validated by comparison with an enzyme-linked immunosorbent assay. This allows confident information about the presence of allergens (even at trace levels) that leads to profitable conditions for both industry and consumers.
- Breast cancer biomarker (HER2-ECD) detection using a molecularly imprinted electrochemical sensorPublication . Pacheco, João; Rebelo, Patrícia; Freitas, Maria; Nouws, Henri; Delerue-Matos, CristinaThe extracellular domain of the human epidermal growth factor receptor 2 (HER2-ECD) is a protein breast cancer biomarker. Its quantification in peripheral blood could provide an important contribution to diagnostics and patient follow-up. In this work an electrochemical molecularly imprinted polymer (MIP) sensor for the quantification of HER2-ECD was developed. The MIP was electropolymerized by cyclic voltammetry using a solution containing phenol and HER2-ECD on a screen-printed gold electrode (AuSPE). The sensor was characterized by cyclic voltammetry and electrochemical impedance spectroscopy. The analysis of HER2-ECD was performed by differential pulse voltammetry using ([Fe(CN)6]3−/4−as redox probe. The linear range was established in the concentration interval from 10 to 70 ng/mL HER2-ECD, with a limit of detection of 1.6 ng/L and a limit of quantification of 5.2 ng/mL. Through the analysis of other protein biomarkers, the MIP sensor was found to be selective. Furthermore, these proteins did not interfere in the analysis of the selected biomarker. The developed sensor was used for the analysis of spiked human serum samples, providing adequate recovery values and precise results. The outcomes of this study indicate that the developed MIP sensor could be useful in the non-invasive analysis of HER2-ECD in breast cancer patients.
- High-performance electrochemical immunomagnetic assay for breast cancer analysisPublication . Freitas, Maria; Nouws, Henri P. A.; Keating, Elisa; Delerue-Matos, CristinaDespite the evolution of targeted therapies in oncology, some challenges such as screening and early diagnosis of cancer-related biomarkers still remain. The analysis of the Human Epidermal growth factor Receptor 2 (HER2) in biological fluids provides essential information for effective treatments. In this work we report the development of an electrochemical immunomagnetic bioassay for the analysis of the extracellular domain of HER2 (HER2-ECD) in human serum and cancer cells. Biomodified carboxylic acid functionalized magnetic beads (COOH-MBs) were used as the capture probe and an antibody labelled with alkaline phosphatase (AP) as the signalling probe. In the presence of HER2-ECD a sandwich complex was formed on the MBs, which were magnetically attracted to the surface of a screen-printed carbon electrode (SPCE). After the addition of 3-indoxyl phosphate and silver ions, used as the enzymatic substrate, the immunological interaction was detected by linear sweep voltammetry. Two linear concentration ranges were established: one between 5.0 and 50 ng/mL and another between 50 and 100 ng/mL. The developed assay provided a clinically useful detection limit (2.8 ng/mL) and has an adequate precision (Vx0 < 5%). The assay provided accurate results and was selective towards the target biomarker. Additionally, CTCs were analysed in human serum and a detection limit of 3 cells/mL was achieved for the HER+ breast cancer cell line SK-BR-3.
- Diamine oxidase-modified screen-printed electrode for the redox-mediated determination of histaminePublication . Torre, Ricarda; Costa Rama, Estefanía; Nouws, Henri; Delerue-Matos, CristinaHistamine is an important biogenic amine because of its role in immune responses and the regulation of physiological functions. It is also used as a food freshness indicator, so its maximum concentration in fish is legally regulated. Although several robust and sensitive methods for histamine detection are already available, it continues to be a challenge to develop simple and portable devices that allow rapid histamine screening at any point of the fish production chain. Thus, in this work, a simple, miniaturized and low-cost sensor for histamine analysis was developed. The construction of the sensor only takes 30 min and consists of the immobilization of the enzyme diamine oxidase on the surface of a screen-printed carbon electrode by cross-linking. The quantification of histamine was achieved by chronoamperometry (+ 0.2V,120 s) using hexacyanoferrate (III) as a redox mediator. This selective sensor provided a low limit of detection (0.97 mg L−1) and accurate and precise results and was successfully applied to the analysis of spiked tuna and mackerel extracts,obtaining recovery values of 99–100%. Moreover, the sensor shows good stability, maintaining 87.7% of its initial signalafter 35 days.
- Removal of diclofenac and sulfamethoxazole from aqueous solutions and wastewaters using a three-dimensional electrochemical processPublication . Soares, Cristina; Correia-Sá, Luísa; Paíga, Paula; Barbosa, Carlos; Remor, Paula Verônica; Freitas, Olga; Moreira, Manuela M.; Nouws, Henri; Correia, Manuela; Ghanbari, Amir; Rodrigues, António J.; Oliveira, Carlos M.; Figueiredo, Sónia; Delerue-Matos, CristinaThe three-dimensional (3D) electrochemical treatment process was studied for the removal of two pharmaceuticals, diclofenac (anti-inflammatory) and sulfamethoxazole (antibiotic), in mono and bi-component systems. Adsorption and conventional two-dimensional electrochemical processes were initially studied and then combined to develop the 3D process. The influence of different operating parameters on the removal efficiency was studied: the distance between the cathode and the anode, the pharmaceutical and electrolyte (NaCl) concentrations, the pH, and the (carbon-based) adsorbent used as particulate electrode (biochar and commercial activated carbon, granulometry, and amount). The energy consumption and the electric energy per order were evaluated. The results demonstrate the efficiency of the 3D process for the removal of diclofenac and sulfamethoxazole from aqueous solutions, both for mono- and bi-component systems, achieving their complete removal respectively in 10 and 30 min, using a Mixed Metal Oxide anode (titanium-coated with RuO2-IrO2-TiO2), a stainless steel cathode, a biochar particulate electrode (1–2 mm), an initial pharmaceutical concentration of 10 mg/L, an inter-electrode distance of 7.5 cm, a pH value of 7 and a current density of 7 mA/cm2. The optimised 3D process was also successfully applied to a wastewater treatment plant effluent, but lower removal efficiencies were observed (after 30 min) for bi-component fortified samples; 49% for DCF and 86% for SMX, with energy consumptions of 1224 and 613 Wh/g and an electric energy per order of 19.1 and 8.77 kWh/m3 respectively. On the other hand, the pharmaceuticals were completely removed from the effluent when real concentrations (i.e. without their addition) were used
- Electrochemical Biosensing in Cancer Diagnostics and Follow-upPublication . Freitas, Maria; Nouws, Henri; Delerue-Matos, CristinaIn cancer, screening and early detection are critical for the success of the patient's treatment and to increase the survival rate. The development of analytical tools for non‐invasive detection, through the analysis of cancer biomarkers, is imperative for disease diagnosis, treatment and follow‐up. Tumour biomarkers refer to substances or processes that, in clinical settings, are indicative of the presence of cancer in the body. These biomarkers can be detected using biosensors, that, because of their fast, accurate and point of care applicability, are prominent alternatives to the traditional methods. Moreover, the constant innovations in the biosensing field improve the determination of normal and/or elevated levels of tumour biomarkers in patients’ biological fluids (such as serum, plasma, whole blood, urine, etc.). Although several biomarkers (DNA, RNA, proteins, cells) are known, the detection of proteins and circulating tumour cells (CTCs) are the most commonly reported due to their approval as tumour biomarkers by the specialized entities and commonly accepted for diagnosis by medical and clinical teams. Therefore, electrochemical immunosensors and cytosensors are vastly described in this review, because of their fast, simple and accurate detection, the low sample volumes required, and the excellent limits of detection obtained. The biosensing strategies reported for the six most commonly diagnosed cancers (lung, breast, colorectal, prostate, liver and stomach) are summarized and the distinct phases of the sensors’ constructions (surface modification, antibody immobilization, immunochemical interactions, detection approach) and applications are discussed.
- Green zero-valent iron nanoparticles for the degradation of amoxicillinPublication . Machado, S.; Nouws, H. P. A.; J.T., Albergaria; Delerue-Matos, CristinaIn the last years, it has been proven that zerovalent iron nanoparticles, including those produced using green methods, are efficient remediation agents for a wide range of target contaminants. However, apart from the known advantages of these green nanomaterials, the knowledge of how they act on distinct contaminants is not yet fully understood and requires further investigation. The objectives of this work were to study the degradation of a common antibiotic, amoxicillin, in water and in a sandy soil using green zero-valent iron nanoparticles (gnZVIs) as reductants and as catalysts for the Fenton reaction. It represents the first study of the use of gnZVI, as alternative for the zero-valent iron nanoparticles produced with sodium borohydride, for the degradation of amoxicillin. The results of the performed tests indicate that gnZVIs have the potential to be used in remediation processes. In both chemical tests, the gnZVI was able to degrade up to 100% of amoxicillin in aqueous solutions, using an amoxicillin/ gnZVI molar ratio of 1:15 when applied as a reductant, and an amoxicillin/H2O2/gnZVI molar ratio of 1:13:1 when applied as a catalyst for the Fenton reaction. The soil tests showed that the required molar ratios for near complete degradation were higher in the reduction test (1:150) than in the gnZVI-catalyzed Fenton reaction (1:1290:73). This is possibly due to parallel reactions with the soil matrix and/or limitations of the reagents to reach the entire soil sample. The degradation efficiencies obtained in these tests were 55 and 97% for the reduction and catalyzed Fenton processes, respectively.
- Preconcentration and sensitive determination of the anti-inflammatory drug diclofenac on a paper-based electroanalytical platformPublication . Costa-Rama, E.; Nouws, H.; Delerue-Matos, Cristina; Blanco-López, M.C.; Fernández-Abedul, M.T.This work describes the development of a paper-based platform for highly sensitive detection of diclofenac. The quantification of this anti-inflammatory drug is of importance in clinical (e.g. quality and therapeutic control) and environmental (e.g. emerging contaminant determination) areas. The easy-to-handle platform here described consists of a carbon-ink paper-based working electrode and two metallic wires, provided by a gold-plated standard connector, as reference and counter electrodes. The porous paper matrix enables the preconcentration of the sample, decoupling sample and detection solutions. Thus, relatively large sample volumes can be used, which significantly improves the sensitivity of the method. A wide dynamic range of four orders of magnitude, between 0.10 and 100 μM, was obtained for diclofenac determination. Due to the predominance of adsorption at the lowest concentrations, there were two linear concentration ranges: one comprised between 0.10 and 5.0 μM (with a slope of 0.85 μA μM-1) and the other between 5.0 and 100 μM (with a slope of 0.48 μA μM-1). A limit of detection of 70 nM was achieved with this simple device that provided accurate results with an RSD of ca. 5%. The platform was applied for diclofenac quantification in spiked tap water samples. The versatility of this design enabled the fabrication of a multiplexed platform containing eight electrochemical cells that work independently. The low cost, small size and simplicity of the device allow on-site analysis, which is very useful for environmental monitoring.
- Impact of magnetite nanoparticles on the syntrophic dechlorination of 1,2-dichloroethanePublication . Leitão, Patrícia; Aulenta, Federico; Rossetti, Simona; Nouws, Henri; Danko, Anthony S.In anaerobic environments microorganisms exchange electrons with community members and with soil and groundwater compounds. Interspecies electron transfer (IET) occurs by several mechanisms: diffusion of redox compounds or direct contact between cells. This latter mechanism may be facilitated by the presence of conductive nanoparticles (NP), possibly serving as electron conduits among microorganisms. Our study examined the effect of magnetite (Fe3O4) NP on the dechlorination of 1,2-dichloroethane (1,2-DCA) by a mixed-culture. The addition of NP (170 mg L− 1 total Fe) enhanced the acetate-driven reductive dechlorination of 1,2-DCA to harmless ethene (via reductive dihaloelimination) up to 3.3-times (2.3 μeq L− 1 d− 1 vs. 0.7 μeq L− 1 d− 1), while decreasing the lag time by 0.8 times (23 days) when compared to unamended (magnetite-free) microcosms. Dechlorination activity was correlated with the abundance of Dehalococcoides mccartyi, which accounted up to 50% of total bacteria as quantified by CARD-FISH analysis, pointing to a key role of this microorganism in the process. Given the widespread abundance of conductive minerals in the environment, the results of this study may provide new insights into the fate of 1,2-DCA and suggest new tools for its remediation by linking biogeochemical mechanisms.
- Disposable electrochemical immunosensor for analysis of cystatin C, a CKD biomarkerPublication . LOPES, Paula; Costa Rama, Estefanía; Beirão, Idalina; Nouws, Henri; Santos-Silva, Alice; Delerue-Matos, CristinaSpecific monitoring of cystatin C (CysC) levels in biological fluids is critical for diagnosis, treatment and mechanistic understanding of a spectrum of diseases, particularly chronic kidney disease (CKD). Despite evidences that CysC correlates with the high risk and/or progression of CKD, its use in clinical practice is still scarce. In this context, we report the development of a simple and sensitive immunosensor for the detection of CysC. The biosensor combines the technology of cost-effective screen-printed electrodes with the high specificity of a sandwich immunoassay. Optimized conditions showed that the sensor operates in a linear range between 10 and 100 ng mL-1, with a detection limit and a sensitivity of 6.0 ng mL-1 and 6.4 ± 0.3 μA ng mL-1 cm-2, respectively. Moreover, the sensor provided precise results (RSD ≤ 6.2%) and the quantification of CysC in CKD serum samples revealed to be in agreement with the values obtained by a particle-enhanced nephelometric immunoassay. In this light, the proposed immunosensor qualifies for clinical application, constituting a step forward in the development of fast, sensitive and cost-effective diagnostic tools that can improve the current medical care settings of CKD patients.